This year’s most-read oncology content of 2024 includes topics on clinical trials, drug access, vaping and lung cancer, and ...

This year's top 5 most-read cardiovascular articles explored topics ranging from FDA approvals to the risks associated with ...

Check out this year's top 5 pieces of sleep coverage that cover topics surveying the benefits of supplements, novel ...

The top content from the Institute for Value-Based Medicine® (IVBM®) highlighted innovative approaches to improving care ...

The high health care burden faced by individuals with hemophilia underscores the urgent need for innovative treatments and ...

In 2024, the most-read articles published in Population Health, Equity & Outcomes (PHEO) highlighted the promise of ...

In addition to new treatments over the past few years changing the landscape for patients, additional treatments being ...

Through interviews and articles infused with expert insight, progress against this cancer that develops in the bone marrow ...

The most-read articles addressing mental health in 2024 spanned therapeutic advancements, research discoveries, and insight ...

Sarah Ahmad, MBA, CEO of the Coalition for Affordable Quality Healthcare (CAQH), dives into the financial, physical, and ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...

The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with ...